Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia

NCT01863225 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia
Coronary Artery Disease

Interventions

DRUG: RVX000222
DRUG: Rosuvastatin
DRUG: Atorvastatin
DRUG: Rosuvastatin
DRUG: Atorvastatin

Sponsor

Resverlogix Corp

Collaborators

[object Object]